Authors
Ismailova D. S.
MD, PhD, CMedSci, Senior Researcher1
1 - Research Institute of Eye Diseases, Moscow
Corresponding author
Ismailova Dilyara; å-mail: d_ismailova@bk.ru
Funding
The study had no sponsorship.
Conflict of interest
None declared.
Abstract
A severe case of corneal damage in patient with thyroid eye disease (TED) is presented. Surgical interventions and medication treatment performed on different disease stages are described. Complex treatment resulted in long-term stabilization and remission of TED. Brief review of literature deals with the problems of etiology, pathogenesis, risk factors and treatment of keratopathy associated with thyroid eye diseases. Treatment of corneal damage in patients with TED may be different and often complex, taking into consideration many factors. The choice of treatment depends on severity of corneal damage and orbital inflammation activity. Surgical treatment may include orbital decompression, lagophthalmos and eyelid retraction correction, corneal and squint surgery.
Key words
thyroid eye disease, corneal ulcer, dry eye syndrome, eyelid retraction, lagophthalmos, orbital decompression, pulse therapy, tarsorhaphy
DOI
References
1. Brovkina A.F. Endokrinnaya oftal'mopatiya [Thyroid eye disease]. Moscow: Geotar-media, 2004. (In Russ.)
2. Grusha Ia.O., Ismailova D.S., Ivanchenko Ju.F., Agafonova E.I. Pervyj opyt primeneniya preparata stabilizirovannoj gialuronovoj kisloty dlya korrekcii lagoftal'ma [The first experience in using the stabilized hyaluronic acid preparation to correct lagophthalmos]. Vestn Oftalmol. [Russian Annals of Ophtalmology] 2010; 126 (1): 39-42. (In Russ.)
3. Grusha Ia.O., Ismailova D.S., Gankovskaia O.A. Faktory riska porazheniya rogovicy u bol'nyh s ehndokrinnoj oftal'mopatiej [Risk factors of corneal damage in patients with Thyroid Eye Disease]. Vestn Oftalmol. [Russian Annals of Ophtalmology] 2010;126(6):35-38 (In Russ.)
4. Grusha Ia.O., Kasparov A.A., Kiseleva T.N., Fedorov A.A., Filimonov G.P., Zaitsev A.V., Polunina A.A., Ismailova D.S. Kombinirovannoe hirurgicheskoe lechenie yazvy rogovicy pri ehndokrinnoj oftal'mopatii [Combined surgical treatment for corneal ulcer in endocrine ophthalmopathy]. Vestn Oftalmol. [Russian Annals of Ophtalmology] 2008; 124(6): 57-59 (In Russ.)
5. Grusha Ia.O., Fedorov A.A., Ismailova D.S. Morfologicheskie izmeneniya kon«yunktivy pri ehndokrinnoj oftal'mopatii [Morphology of conjunctival changes in thyroid eye disease]. Vestn Oftalmol. [Russian Annals of Ophtalmology] 2011; 127 (2): 31-35 (In Russ.)
6. Grusha Y.O., Fedorov A.A., Sheptulin V.A. In»ekcionnye implantaty na osnove gelya gialuronovoj kisloty pri patologii pridatochnogo apparata glaza [Injectable hyaluronic acid gel implants in adnexal diseases]. Moscow: Geotar-media, 2017. (In Russ.)
7. Brasil M.V., Brasil O.F., Vieira R.P., Vaisman M., Amaral Filho O.M. Tear film analysis and its relation with palpebral fissure height and exophthalmos in Graves' ophthalmopathy. Arq Bras Oftalmol. 2005; 68(5): 615-8.
8. Chaly Y.V., Paleolog E.M., Kolesnikova T.S., Tikhonov I.I., Petratchenko E.V., Voitenok N.N. Human neutrophil α-defensin modulates cytokine production in human monocytes and adhesion molecules expression in endothelial cells. Eur Cytokine Netw. 2000; 11: 257-266.
9. Cho R.I., Elner V.M., Nelson C.C., Frueh B.R. The effect of orbital decompression surgery on lid retraction in thyroid eye disease. Ophthal Plast Reconstr Surg. 2011; 27 (6): 436-8.
10. Della Rocca R. Thyroid-related orbithopathy: concepts and management. Facial Plast Surg. 2007: 23: 168-173.
11. Eckstein A.K., Finkenrath A., Heiligenhaus A., Renzing-Kohler K., Esser J., Krüger C., Quadbeck B., Steuhl K.P., Gieseler R.K. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor-specific autoantibodies. Acta Ophthalmol Scand. 2004; 82: 291-297.
12. Gilbard G.P., Farris R.L. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta ophthalmol. 1983; 61 (1): 108-116.
13. Heinz C., Eckstein A., Steuhl K.P., Meller D. Amniotic membrane transplantation for reconstruction of corneal ulcer in graves ophthalmopathy. Cornea. 2004; 23(5): 524-6.
14. Ismailova D.S., Fedorov A.A., Grusha Y.O. Ocular surface changes in thyroid eye disease. Orbit. 2013; 32 (2): 87-90.
15. Nowak M., Marek B. Kos-Kudła B, Kajdaniuk D, Siemińska L. Tear film profile in patients with active thyroid orbithopathy. Klin Oczna 2005; 107: 479-82.
16. Rajabi M.T., Jafari H., Mazloumi M., Tabatabaie S.Z., Rajabi M.B., Hasanlou N., Abtahi S.M., Goldberg R.A. Lower lid retraction in thyroid orbitopathy: lamellar shortening or proptosis? Int Ophthalmol. 2014; 34 (4) :801-4.
17. Solomon A., Meller D., Prabhasawat P., John T., Espana E.M., Steuhl K.P., Tseng S.C. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 2002; 109 (4): 694-703.
18. Verity D.H., Rose G.E. Acute thyroid eye disease (TED): principles of medical and surgical management. Eye (Lond.) 2013; 27 (3): 308-19.
19. Wells J.R., Michelson M.A. Diagnosing and Treating Neurotrophic keratopathy. Ophthalmic Pearls. Available at: www.aao.org